This randomised, double-blind study was designed to compare the duration of analgesia and adverse effects following intrathecal administration of dexmedetomidine or clonidine, both with bupivacaine, in trauma patients. ninety adult trauma patients of American Society of Anesthesiologists physical status I-II, scheduled for lower limb surgery under subarachnoid block, were randomly allocated to one of three groups. All groups received hyperbaric bupivacaine 0.5% 3 ml, to which was added saline 0.5 ml (Group B): clonidine 50 µg (Group C) or dexmedetomidine 5 µg (Group D). The onset and duration of sensory and motor blockade, severity of postoperative pain, time to first rescue analgesia and total analgesic requirement for 24 hours were noted. There was no significant difference in the onset time of the block but the duration of sensory and motor blockade was prolonged in Groups C and D, compared with Group B. The time to analgesia was significantly prolonged in Group D (824±244 minutes) compared with Group C (678±178 minutes; P=0.01), the latter being longer than Group B (406±119 minutes; P=0.0001). Postoperative pain scores were lower in Groups C and D compared with Group B. The requirement for rescue analgesia during the first 24 postoperative hours was significantly less in Groups C and D as compared to Group B (P=0.0001), but comparable between Group C and D (P=0.203).
Regional anaesthesia techniques are used extensively for lower limb procedures in trauma patients. They have the major potential advantages of reduced blood loss, reduced deep vein thrombosis and better pain control in the early postoperative period, depending on the technique used 1, 2 . Good pain control has the potential to allow earlier hospital discharge and may improve the patient's ability to tolerate physical therapy. Adjuvants such as morphine, fentanyl and clonidine have been used to supplement intrathecal local anaesthetics, providing possible advantages such as delayed onset of pain and reduced analgesic requirements. Clonidine prolongs the dur-ation of spinal blockade as well as postoperative analgesia [3] [4] [5] but at the expense of dose-dependent hypotension and sedation [6] [7] within the therapeutic range 150-300 µg.
Dexmedetomidine possesses selective α 2 -adrenoceptor agonist activity, especially for the 2A receptor subtype, making it a more effective analgesic than clonidine and free of undesirable cardiovascular effects related to α 1 -receptor activation 8 . A clinical study reported that intrathecal administration of equipotent doses of dexmedetomidine and clonidine produced similar effects on the onset and duration of sensory and motor blockade in patients undergoing urology procedures 9 . However, there is little in the literature about the postoperative analgesic effects of intrathecal dexmedetomidine. Therefore, this randomised, double-blind study was planned to compare the postoperative analgesic efficacy (as the primary outcome) and adverse effects (as the secondary outcome) after intrathecal administration of dexmedetomidine and clonidine with hyperbaric bupivacaine to trauma patients undergoing lower limb surgery.
METHODS
Institutional ethics committee approval (MS/1232/ Dept/1666, 29 July 2010) was obtained and the study was registered in the Clinical Trial Registry, India (REF/2012/09/004022). Written informed consent was obtained from 94 trauma patients aged 18-65 years, of American Society of Anesthesiologists (ASA) physical status I-II who were scheduled for lower limb surgery of less than three hours duration. Patients were randomly assigned in an equal ratio, using a computer-generated random number table, to one of three groups. All groups received intrathecal hyperbaric bupivacaine 15 mg, supplemented with saline 0.5 ml (Group B); clonidine 50 µg in normal saline 0.5 ml (Group C); or dexmedetomidine 5 µg in normal saline 0.5 ml (Group D). Clonidine 50 µg was prepared by diluting clonidine 150 µg (Cloneon 150 µg/ml, preservative free, Neon Laboratories, India) in normal saline 1.5 ml. Dexmedetomidine 5 µg (Dextomid 100 µg/ml, Neon Laboratories, India) was drawn up using a 1 ml Tuberculin syringe with 0.01 ml markings and then diluted in preservative-free normal saline to 0.5 ml. One anaesthetist prepared the intrathecal drugs just prior to positioning the patient for spinal anaesthesia. A second anaesthetist who was blinded to the study drug attended intraoperatively and collected data in the postoperative period.
All patients had two 18-gauge intravenous cannulae and received intravenous fluid at an initial rate of 10 ml/kg/hour. Baseline haemodynamic parameters were recorded and with aseptic precautions a lumbar puncture was performed at L3-L4 using a 26-gauge Quincke spinal needle with the patient seated. After confirming the free flow of cerebrospinal fluid, the study drug solution (3.5 ml) was injected by an anaesthetist blinded to the group assignment. The patients were placed supine after injection and the sensory level was assessed by pinprick sensation using a blunt 25-gauge needle along the mid-clavicular line bilaterally at three-minute intervals for 30 minutes, and then every 15 minutes after. The time to reach T10 dermatome (onset time) and the maximum sensory level were recorded, as were time to two segment regression and to S1 segment regression (the duration of sensory block). The motor block was assessed according to the modified Bromage scale (0-3), for onset (time to reach maximum Bromage level) and duration (time to Bromage 0 regression).
All patients were monitored for heart rate (HR), blood pressure, oxygen saturation, respiratory rate and level of sedation, every two minutes for the first ten minutes and then every five minutes until the end of surgery and then in the recovery room. Sedation was scored 0-3 (0=awake and oriented, 1=sedated but rousable, 2=rousable with deep stimulation and 3=not rousable). Hypotension (mean arterial pressure <60 mmHg) was treated with intravenous mephentermine, and bradycardia (HR <50/minute) was treated with intravenous atropine. need for supplemental intraoperative analgesia (intravenous [IV] morphine), sedation (IV midazolam) or general anaesthesia was noted.
Postoperatively patients were observed for haemodynamic parameters, sedation and pain in the recovery room for six hours and then in the postsurgical ward for 24 hours. Severity of pain was assessed using a verbal numerical rating scale of 0-10 (0=no pain, 10=worst pain imaginable) at hourly intervals for six hours and then at eight, ten, 12, 15, 18 and 24 hours, by nursing staff who were unaware of the group assignment. Postoperative analgesic rescue was provided by diclofenac sodium 75 mg intramuscularly (if verbal numerical rating scale >3) and if not controlled within 30 minutes, by IV morphine 3 mg boluses. The time to request rescue analgesia (the duration of analgesia), the frequency of rescue analgesia and the 24-hour diclofenac and morphine requirement were recorded. Side-effects such as nausea, vomiting, respiratory depression, shivering, urinary retention and pruritus were treated accordingly.
Statistical analysis
The sample size calculation was done a priori (α=0.05 and β=0.90) using statistical software G Power 3.1. A sample size of 30 in each group was based on a desire to detect a difference in mean duration of analgesia between clonidine and dexmedetomidine of 150 minutes (standard deviation 100 minutes). The statistical analysis was conducted using Statistical Package for Social Sciences (SPSS Inc., Chicago, IL, version 15.0 for Windows). All quantitative variables were estimated using measures of central location (mean, median) and measures of dispersion (standard deviation). Normality of data was checked by measures of skewness and kolmogorov Smirnov tests of normality. For normally distributed data, means were compared using one-way analysis of variance and, if appropriate, a subsequent Bonferroni test for post hoc analysis. For time-dependent changes, repeated measures analysis of variance were applied. For skewed data, the kruskal Wallis test was applied. Qualitative or categorical variables are described as frequencies and proportions. Proportions were compared using the chi-square or Fisher's exact test, as applicable. All statistical tests were two-sided and were performed at a significance level of α=0.05. 
RESuLTS
ninety-four patients were enrolled, but four patients (two from Group D and one each from Groups C and B) were excluded (two needed conversion to general anaesthesia due to failed block and two received intraoperative morphine). This left 90 patients in the final analysis. The demographic data and duration of surgery were comparable across groups (Table 1) . There was no significant difference in the mean time to reach T10 sensory block or the time to reach peak sensory level (Table 2 ) and the peak sensory block achieved was comparable (P=0.127). The time to regression of sensory blockade by two dermatomes or to the S1 dermatome was significantly prolonged in Groups C and D compared with Group B (Table 2) , but sensory regression times did not differ between Groups C and D. The time taken to reach a Bromage score 3 was comparable across groups (P=0.978). The Values are mean ± standard deviation. y=years, min=minutes, ASA=American Society of Anesthesiologists physical status. Values are mean ± standard deviation except peak sensory level (median, interquartile range). # P <0.0001 compared with Groups C and D. min=minutes. regression time to Bromage score 0 was prolonged in Groups C and D versus Group B but did not differ between Groups C and D ( Table 2) . Pain scores were significantly lower in Groups C and D, compared with Group B at the third, fourth, fifth, sixth and eighth hours postoperatively (P=0.0001). Scores for Groups C and D did not differ significantly. The time to first rescue analgesia was significantly prolonged in Group D compared with Group C (P=0.01), and in Group C compared with Group B (P=0.0001). The total dose of rescue analgesia was significantly less in Group C and D as compared to Group B (P=0.0001), but compareable between Group C and D (P=0.203) ( Table 3) .
The HR and mean arterial pressure were comparable for all groups during the intraoperative and postoperative periods (Figures 1 and 2) . Two patients in Group D and one patient in each of Groups C and B had episodes of bradycardia that needed intervention. Hypotensive episodes needing treatment were experienced by seven patients each in Groups C and D, and five patients in Group B (P=nS). Although patients in Groups C and D had higher sedation scores compared with Group B (P=0.024), none were deeply sedated or had respiratory depression. All patients had peripheral oxygen saturation >96% at all times and none required oxygen therapy. In total, two patients in Group C, three patients in Group D and two patients in Group B experienced shivering, and seven patients in Group C, eight patients in Group D and six patients in Group B experienced nausea.
DISCuSSIOn
In this study of trauma patients undergoing lower limb surgery, supplementation of spinal bupivacaine with dexmedetomidine 5 µg significantly prolonged the duration of postoperative analgesia compared with the addition of clonidine 50 µg. Both dexmedetomidine and clonidine prolonged both sensory and motor blockade, improved the quality of postoperative analgesia and reduced the need of rescue analgesia for the first 24 postoperative hours.
Intrathecal α 2 -adrenoceptor agonists produce analgesia by depressing the release of C-fibre neurotransmitters and by hyperpolarisation of post-synaptic dorsal horn neurons [10] [11] . This antinociceptive effect may explain the prolongation of the sensory block, while prolongation of motor block may result from the binding of α 2 -adrenoceptor agonists to motor neurons in the dorsal horn 12 . Addition of intrathecal clonidine to local anaesthetic prolongs the duration of postoperative analgesia and reduces morphine requirements in orthopaedic patients [3] [4] . Similarly, dexmetedomidine 5 µg added to plain bupivacaine 10 mg or hyperbaric bupivacaine 12.5 mg increases the duration of motor and sensory block compared with the addition of fentanyl 25 µg [13] [14] .
The binding affinity of dexmedetomidine to the spinal α 2 -adrenoreceptor is approximately ten times higher than clonidine 15 . Intrathecal dexmedetomidine and clonidine, when used in 1:10 dose ratio, produce similar effects in animals 8, 15 . Kanazi et al 9 found that dexmedetomidine 3 µg and clonidine 30 µg added to bupivacaine produced a similar prolongation in the duration of the motor and sensory block, with preservation of haemodynamic stability and lack of sedation, among patients undergoing urology procedures and on this basis we assumed intrathecal dexmedetomidine 5 µg would be equipotent to intrathecal clonidine 50 µg. However, although the durations and block characteristics were similar, the duration of postoperative analgesia was prolonged more by dexmedetomidine.
The addition of dexmedetomidine or clonidine to intrathecal bupivacaine did not cause a significant decrease in the blood pressure or heart rate, either intraoperatively or postoperatively. The block of sympathetic outflow is near maximal at the usual doses used for subarachnoid block, so it is not or only minimally affected by an inclusion of a low dose of α 2 -agonist 16 . Strebel et al 4 examined the effects of small doses (37.5-150 µg) of intrathecal clonidine with hyperbaric bupivacaine 0.5% 18 mg in orthopaedic patients and found that it prolonged the anaesthetic and analgesic effects of bupivacaine in a dose-dependent manner. Doses up to 150 µg had no undesirable side-effects, but higher doses of clonidine can cause marked hypotension and sedation [6] [7] . The doses of clonidine and dexmedetomidine we studied were at the lower end of the dosing spectrum, probably explaining the lack of marked sedation from either drug. Dexmedetomidine 1.5-2.0 µg/kg has been administered epidurally to humans without report of neurological deficit [17] [18] , but the safety of a dexmedetomidine solution for intrathecal injection in humans has not been extensively studied. Kanazi et al 9 and Al-Ghanem et al 13 , in two independent human studies, used intrathecal dexmedetomidine without any adverse neurological consequences. Various preclinical animal neurotoxicity studies, using dexmedetomidine in a dose range from 2.5-100 µg, failed to identify untoward neurological effects [19] [20] [21] . Similarly, intrathecal dexmedetomidine 100 µg did not produce neurological deficits in a sheep model that included a seven-day follow-up 19 .
Our study has limitations. As all patients were either ASA physical status I or II, results cannot be generalised to ASA physical status III and IV patients. Our patients were free of significant comorbidities that might have exaggerated the cardiovascular side-effects of intrathecal clonidine or dexmedetomidine. Further dose-response studies are needed to determine the optimal effective dose of intrathecal dexmedetomidine. The effect of intrathecal clonidine or dexmedetomidine when combined with intrathecal opioid has also not been investigated and randomised controlled trials are needed.
In conclusion, this study showed that dexmedetomidine 5 µg, when added to intrathecal bupivacaine 15 mg, produced longer postoperative analgesia than clonidine 50 µg, and did not cause undesirable sideeffects among trauma patients undergoing lower limb surgery. The addition of dexmedetomidine to intrathecal bupivacaine also prolonged the duration of sensory and motor block and significantly reduced rescue analgesic requirements. Prolonging motor block could be particularly useful during longer orthopaedic procedures.
